Pediatric Obesity study: Continuous glucose monitor
Official title Use of Continuous Glucose Monitors in Children and Adolescents With Obesity
ClinicalTrials.gov ID: NCT06254768
What this study is testing
- What it's testing
- The study aims to find out if it is practical and possible to use continuous glucose monitors in children and adolescents who have obesity.
- Who it's for
- The study is looking for children and adolescents who have obesity.
- What's involved
- Participants will use a continuous glucose monitor, which is a small device worn on the skin to track blood sugar levels.
- Time commitment
- The source text does not specify the duration of the study or the number of visits required.
This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 10 to 21. Healthy volunteers may be eligible.
You may be able to join if
- Age 10-21 years BMI \>95th percentile
You likely can't join if
- Previous diagnosis of Prader Willi Syndrome or hypothalamic obesity
- Intellectual disability
- Previous or planned bariatric surgery
- Hemoglobin A1c \>6.5 %
- Current use of medication that impacts weight
The study team makes the final eligibility decision.
Where it is enrolling
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 10 years to 21 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Los Angeles, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.